Table 2.

Cumulative incidence of GVHD

	180-day acute GVHD II–IV	180-day acute GVHD III–IV	2-year chronic GVHD	2-year ext. chronic GVHD
PTCY	28.8% [22.2–35.7]	8.8% [5.1–13.7]	31.4% [23.3–39.8]	18.5% [12–26.1]
ATG	29.2% [26.8–31.6]	9% [7.6–10.6]	33.6% [31–36.2]	13.1% [11.2–15]
pvalue	0.68	0.89	0.43	0.11

Abbreviations: ATG antithymocyte globulin, Ext extensive, GVHD graft-versus host disease, PTCY post-transplantation cyclophosphamide